Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.,The Journal of Infectious Diseases

当前位置： X-MOL 学术 › J. Infect. Dis. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
The Journal of Infectious Diseases ( IF 5.0 ) Pub Date : 2020-06-21 , DOI: 10.1093/infdis/jiaa363
Ying Chi ₁ , Yiyue Ge ₁ , Bin Wu ₁ , Wenshuai Zhang ₁ , Tao Wu ₁ , Tian Wen ₁ , Jingxian Liu ₁ , Xiling Guo ₁ , Chao Huang ₁ , Yongjun Jiao ₁ , Fengcai Zhu ₁ , Baoli Zhu _{1,

2} , Lunbiao Cui ₁

Affiliation

Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We investigated the serum cytokine and chemokine levels in asymptomatic, mild, moderate, severe, and convalescent SARS-CoV-2–infected cases. Proinflammatory cytokine and chemokine production induced by SARS-CoV-2 were observed not only in symptomatic patients but also in asymptomatic cases, and returned to normal after recovery. IL-6, IL-7, IL-10, IL-18, G-CSF, M-CSF, MCP-1, MCP-3, IP-10, MIG, and MIP-1α were found to be associated with the severity of COVID-19. Moreover, a set of cytokine and chemokine profiles were significantly higher in SARS-CoV-2–infected male than female patients. The serum levels of MCP-1, G-CSF, and VEGF were weakly and positively correlated with viral titers. We suggest that combinatorial analysis of serum cytokines and chemokines with clinical classification may contribute to evaluation of the severity of COVID-19 and optimize the therapeutic strategies.

更新日期：2020-08-04

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文